Therapeutic Uses
Antiretroviral / Anti-HIV
Storage Condition
For long term usage store at 2-8?C
Synonyms
Tenofovir Ethyl Monoisoproxil
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
No -Refer MSDS for accurate information
Mono-POC Ethyl Tenofovir is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Mono-POC Ethyl Tenofovir usage and description
Mono-POC Ethyl Tenofovir is a novel prodrug of Tenofovir, which is used in the treatment of HIV and Hepatitis B virus infections. It is a nucleotide analog reverse transcriptase inhibitor that works by blocking the replication of the virus. Mono-POC Ethyl Tenofovir is designed to improve the bioavailability and pharmacokinetics of Tenofovir, thereby reducing the frequency of dosing and minimizing adverse effects.
The chemical structure of Mono-POC Ethyl Tenofovir consists of a phosphonamidate prodrug linked to a lipophilic ethyl group. The lipophilic nature of this compound allows for increased cellular uptake and better distribution into the target cells. The prodrug is selectively activated by esterases in the plasma and liver, releasing the active form of Tenofovir.
Mono-POC Ethyl Tenofovir is administered orally and has been studied in clinical trials for its safety and efficacy. It has shown promising results in reducing viral load and improving immune function in HIV-infected patients. Additionally, it has been found to be effective in the treatment of chronic Hepatitis B infections.
In conclusion, Mono-POC Ethyl Tenofovir is a prodrug of Tenofovir that has been designed to improve its bioavailability and pharmacokinetics. It has shown promising results in the treatment of HIV and Hepatitis B virus infections and may offer a safer and more effective alternative to current therapies.
